Skip to main content

DNB Asset Management AS

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1456670 Oslo, Q8

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$33,517,895
-$2,109,308 QoQ
Shares Held
43,381
-6.0% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DNB Asset Management AS holds $242,159,625 across 67 Biotechnology names. REGN ranks #3 (13.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 REGN
Regeneron Pharmaceuticals, Inc.
This page
43,381 $33,517,895

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $33,517,895 43,381
2025-12-31 $35,627,203 46,157
2025-09-30 $26,579,065 47,271
2025-06-30 $24,493,875 46,655
2025-03-31 $31,792,047 50,127
2024-12-31 $25,504,263 35,804
2024-09-30 $34,816,017 33,119
2024-06-30 $34,084,902 32,430
2024-03-31 $30,062,412 31,234
2023-12-31 $28,362,618 32,293
2023-09-30 $25,315,072 30,761
2023-06-30 $21,038,132 29,279
2023-03-31 $17,901,724 21,787
2022-12-31 $14,813,632 20,532
2022-09-30 $14,289,230 20,743
2022-06-30 $18,255,867 30,883
2022-03-31 $22,732,872 32,549
2021-12-31 $21,357,374 33,819
2021-09-30 $24,357,284 40,248
2021-06-30 $26,413,915 47,291
2021-03-31 $19,917,301 42,096
2020-12-31 $17,925,313 37,104
2020-09-30 $20,325,052 36,309
2020-06-30 $48,390,874 77,593
2020-03-31 $32,395,600 66,345